Pharmaceutical company AstraZeneca has launched Evinova, positioning itself as a forefront provider of digital health solutions tailored to the evolving needs of healthcare professionals, regulators, and patients. With steadfast backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova aims to deliver globally scalable digital products and services to the life sciences and healthcare sector.
Evinova’s primary focus is to introduce established and scaled digital technology solutions, already implemented worldwide by AstraZeneca, to optimize clinical trial design and delivery. This strategic move is anticipated to expedite the development of new medicines, bring patient care closer to home, and alleviate the burden on healthcare systems by reducing time and costs. Additionally, Evinova will explore opportunities in digital remote patient monitoring and digital therapeutics, boasting a robust pipeline of innovations in these domains.
Leveraging AstraZeneca’s extensive experience in developing novel therapeutics and insights gathered from thousands of patients and clinical researchers, Evinova aims to provide established technology solutions to pharmaceutical companies, biotechs, and Contract Research Organizations (CROs) globally. These technologies have already demonstrated success in multiple AstraZeneca-sponsored clinical trials across more than 40 countries.
Pascal Soriot, CEO of AstraZeneca, emphasized the potential of digital solutions in accelerating medicine development, stating, “The future of medicine development can be accelerated with digital solutions. We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale provides a real opportunity to fundamentally improve patient care, drive healthcare transformation, and reduce carbon emissions.”
Cristina Duran, President of Evinova, expressed excitement about bringing globally-scaled digital solutions from AstraZeneca’s drug development pipeline to the broader life sciences community. Evinova aims to play a pivotal role in advancing digital health by offering science-based, evidence-led, and human experience-driven solutions to enhance patient experience and outcomes.
Leading Contract Research Organizations (CROs) Parexel and Fortrea have entered into agreements to provide Evinova’s digital health solutions to their extensive customer base. Evinova is also collaborating with Accenture and Amazon Web Services to accelerate industry adoption and expand the global reach of its digital products.
